EP 2587917 A4 20150506 - ANTI-FIBROBLASTIC FLUOROCHEMICAL EMULSION THERAPIES
Title (en)
ANTI-FIBROBLASTIC FLUOROCHEMICAL EMULSION THERAPIES
Title (de)
FLUORCHEMISCHE ANTIFIBROBLASTEN-EMULSIONSTHERAPIEN
Title (fr)
THÉRAPIES AU MOYEN D'ÉMULSIONS FLUOROCHIMIQUES ANTIFIBROBLASTIQUES
Publication
Application
Priority
- US 39882410 P 20100701
- US 2011042815 W 20110701
IPC 8 full level
A61K 31/02 (2006.01); A61K 9/12 (2006.01); A61K 31/03 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP)
A61K 9/0048 (2013.01); A61K 9/0078 (2013.01); A61K 9/124 (2013.01); A61K 31/00 (2013.01)
Citation (search report)
- [XY] WO 9640057 A2 19961219 - ALLIANCE PHARMA [US], et al
- [XY] US 5980936 A 19991109 - KRAFFT MARIE-PIERRE [FR], et al
- [XY] WO 9924016 A1 19990520 - SONUS PHARMA INC [US], et al
- [XY] US 4366169 A 19821228 - WHITE DAVID C
- [XY] US 4452818 A 19840605 - HAIDT STERLING J [US]
- [XY] US 2005119330 A1 20050602 - KAO PETER N [US], et al
- [XY] US 5874481 A 19990223 - WEERS JEFFRY G [US], et al
- [XY] WO 8400686 A1 19840301 - SUN TECH INC [US]
- [XY] US 5733939 A 19980331 - FUHRMAN BRADLEY PHILLIP [US], et al
- [XY] US 2010144861 A1 20100610 - HUVARD GARY [US], et al
- [XY] US 2007190183 A1 20070816 - GREEN FRANCIS H Y [CA], et al
- [XY] US 2008019926 A1 20080124 - KRAFFT MARIE-PIERRE [FR], et al
- [XY] RIESS J G ET AL: "ADVANCED FLUOROCARBON-BASED SYSTEMS FOR OXYGEN AND DRUG DELIVERY, AND DIAGNOSIS", ARTIFICIAL CELLS, BLOOD SUBSTITUTES, AND IMMOBILIZATION BIOTECHNOLOGY, MARCEL DEKKER INC, US, vol. 25, no. 1/02, January 1997 (1997-01-01), pages 43 - 52, XP001064197, ISSN: 1073-1199, DOI: 10.3109/10731199709118896
- [XY] TEICHER B A: "Combination of perfluorochemical emulsions and carbogen breathing with cancer chemotherapy.", ARTIFICIAL CELLS, BLOOD SUBSTITUTES, AND IMMOBILIZATION BIOTECHNOLOGY 1994, vol. 22, no. 4, 1994, pages 1109 - 1120, XP009181239, ISSN: 1073-1199
- [XY] TEICHER BEVERLY A ET AL: "Effect of Fluosol-DA/O2 on tumor-cell and bone-marrow cytotoxicity of nitrosoureas in mice bearing FSA-II fibrosarcoma.", INTERNATIONAL JOURNAL OF CANCER, vol. 38, no. 2, 15 August 1986 (1986-08-15), pages 285 - 288, XP055152882, ISSN: 0020-7136
- [Y] BARTUSIK D ET AL: "Detection of fluorine labeled Herceptin using cellular <19>F MRI ex vivo", JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, NEW YORK, NY, US, vol. 51, no. 4, 11 March 2010 (2010-03-11), pages 894 - 900, XP026813980, ISSN: 0731-7085, [retrieved on 20091014]
- [XY] LANE T A: "Perfluorochemical-based artificial oxygen carrying red cell substitutes", TRANSFUSION SCIENCE, PERGAMON PRESS, OXFORD, GB, vol. 16, no. 1, March 1995 (1995-03-01), pages 19 - 31, XP004568651, ISSN: 0955-3886, DOI: 10.1016/0955-3886(94)00067-T
- [I] LONGLEY D B ET AL: "5-FLUOROURACIL: MECHANISMS OF ACTION AND CLINICAL STRATEGIES", NATURE REVIEWS. CANCER, NATUR PUBLISHING GROUP, LONDON, GB, vol. 3, no. 5, May 2003 (2003-05-01), pages 330 - 338, XP008039669, ISSN: 1474-175X, DOI: 10.1038/NRC1074
- [Y] CENTIS CENTIS ET AL: "Perfluorocarbon Emulsions Cytotoxic Effects on Human Fibroblasts and Effect of Aging on Particle Size Distribution", ARTIFICIAL ORGANS, vol. 31, no. 8, August 2007 (2007-08-01), pages 649 - 653, XP055152542, ISSN: 0160-564X, DOI: 10.1111/j.1525-1594.2007.00437.x
- [Y] EJ WAKE ET AL: "Changes in human cultured cells exposed to a perfluorocarbon emulsion", TRANSFUSION, vol. 25, no. 1, January 1985 (1985-01-01), pages 73 - 77, XP055152534, ISSN: 0041-1132, DOI: 10.1046/j.1537-2995.1985.25185116510.x
- See references of WO 2012003457A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
DOCDB simple family (application)
EP 11801499 A 20110701